Relaxin-1 human
SIGMA/R2156 - recombinant, expressed in E. coli, >95% (SDS-PAGE), lyophilized powder
Synonym: RLN1; RLXH1; Relaxin 1
CAS Number: 2222237-37-6
Product Type: Chemical
| assay | >95% (SDS-PAGE) |
| biological source | human |
| form | lyophilized powder |
| mol wt | (Contains two disulfide-linked subunits: A chain ~2.8 kDa B chain ~3.3 kDa) |
| Quality Level | 100 ![]() |
| recombinant | expressed in E. coli |
| storage temp. | −20°C |
| suitability | endotoxin tested |
| technique(s) | cell culture | mammalian: suitable |
| UniProt accession no. | P04808 ![]() |
| Biochem/physiol Actions: | Relaxin 1 may function in regulating blood pressure, controlling heart rate, and releasing oxytocin and vasopressin |
| Biochem/physiol Actions: | Relaxin has been shown to have antifibrotic effects in renal fibroblasts through mechanisms that increase collagenase activity and via TGF-β signaling. |
| General description: | Cell signaling hormone that is prominent in the prostate, and belongs to the insulin superfamily |
| Physical form: | Lyophilized powder containing BSA |
| Preparation Note: | In Phosphate buffered saline solution containing at least 0.1% serum albumin. The concentration should be ≥10 μg/mL |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | >95% (SDS-PAGE) |
| Storage Temp. | −20°C |
| UNSPSC | 12352202 |

